Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 1
2020 2
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine.
Santoro F, Donato A, Lucchesi S, Sorgi S, Gerlini A, Haks MC, Ottenhoff THM, Gonzalez-Dias P, Consortium VE, Consortium VE, Nakaya HI, Huttner A, Siegrist CA, Medaglini D, Pozzi G. Santoro F, et al. Among authors: lucchesi s. Vaccines (Basel). 2021 Jan 20;9(2):67. doi: 10.3390/vaccines9020067. Vaccines (Basel). 2021. PMID: 33498214 Free PMC article.
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine.
Ciabattini A, Pastore G, Fiorino F, Polvere J, Lucchesi S, Pettini E, Auddino S, Rancan I, Durante M, Miscia M, Rossetti B, Fabbiani M, Montagnani F, Medaglini D. Ciabattini A, et al. Among authors: lucchesi s. Front Immunol. 2021 Sep 28;12:740708. doi: 10.3389/fimmu.2021.740708. eCollection 2021. Front Immunol. 2021. PMID: 34650563 Free PMC article.
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses.
Pettini E, Ciabattini A, Pastore G, Polvere J, Lucchesi S, Fiorino F, Montagnani F, Bucalossi A, Tozzi M, Marotta G, Medaglini D. Pettini E, et al. Among authors: lucchesi s. Blood Adv. 2022 Jan 24:bloodadvances.2021006599. doi: 10.1182/bloodadvances.2021006599. Online ahead of print. Blood Adv. 2022. PMID: 35073574 No abstract available.